Use of Reverse Transcription-PCR-Based Assays for Quantification of HIV-1 in Dried Blood Spots Requires Specific HIV-1 RNA Isolation for Monitoring of Antiretroviral Treatment Efficiency
Author(s) -
François Rouet,
Dramane Kania,
Édouard Tuaillon,
Almoustapha Issiaka Maïga,
Janin Nouhin,
Christine Rouzioux,
Diane Descamps,
JeanChristophe Plantier
Publication year - 2014
Publication title -
journal of clinical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.349
H-Index - 255
eISSN - 1070-633X
pISSN - 0095-1137
DOI - 10.1128/jcm.00962-14
Subject(s) - dried blood spot , reverse transcriptase , virology , dried blood , viral load , human immunodeficiency virus (hiv) , rna , biology , drug resistance , isolation (microbiology) , spots , antiretroviral treatment , rna extraction , lentivirus , viral disease , antiretroviral therapy , microbiology and biotechnology , genetics , gene , chemistry , chromatography , botany
The paper published by the ANRS 12235 Study Group ([1][1]) showed that monitoring of “real-life” HIV-1 RNA viral load (VL) and drug resistance mutations (DRMs) in dried blood spot (DBS) specimens collected from patients in Africa and Asia was possible, but with some limitations, particularly for
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom